27510EGP
- Active ingredient
- trifluridine+tipiracil
- Strength
- 20/8.19mg
- Form
- tablet
- Manufacturer
- taiho pharmaceutical co. ltd. > servier
- Route
- oral.solid
Uses
Used in adults with previously treated metastatic colorectal cancer and certain advanced gastric or gastroesophageal cancers.
Do not use if
No specific contraindications are listed, except hypersensitivity to the product.
Side effects
Common adverse effects include neutropenia, anemia, thrombocytopenia, fatigue, nausea, diarrhea, and decreased appetite.
Warnings
Monitor blood counts regularly due to risk of severe myelosuppression. May cause fetal harm.
How it works
Combines a nucleoside analog that interferes with cancer cell replication and an inhibitor that increases its exposure.
Storage
Store at room temperature in the original package.
